Efektivitas HE4 sebagai Metode Skrining Terbaru untuk Diagnosis Dini Kanker Ovarium | Zendy

Amru Sofian | Zendy; Hendra Perkasa | Zendy; Ega Rahman Evsya | Zendy; Riyan M Darundryo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efektivitas HE4 sebagai Metode Skrining Terbaru untuk Diagnosis Dini Kanker Ovarium

Author(s) -

Amru Sofian,

Hendra Perkasa,

Ega Rahman Evsya,

Riyan M Darundryo

Publication year - 2017

Publication title -

jurnal ilmu kedokteran (journal of medical science)

Language(s) - English

Resource type - Journals

eISSN - 2715-4467

pISSN - 1978-662X

DOI - 10.26891/jik.v5i2.2011.88-93

Subject(s) - epididymis , ovarian cancer , biomarker , medicine , cancer , gynecology , andrology , oncology , biology , sperm , biochemistry

The tumor marker CA125 is one of the currently used biomarkers to detect ovarian cancer. The tumormarker CA125 also elevated in other diseases. Human epididymis protein 4 is used as a new biomarker forearly detection of ovarian cancer. Human epididymis protein 4 is increased in almost all patients withovarian cancer and increased only slightly at a fraction of other diseases. Human epididymis protein 4 hasa better effectiveness in detecting ovarian cancer when combined with CA125. From the study of literaturefound that the combination of HE4 and CA125 had a specificity of 96.3% and 92.9% sensitivity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research